Introduction
============

Immunoglobulin G4-related disease (IgG4-RD) is a new clinicopathological entity, which was first reported in 2001 in the case of autoimmune pancreatitis by Hamano et al. in Japan.^[@R1])^ IgG4-RD is characterized by elevated serum immunoglobulin G4 (IgG4) level, diffuse or localized tissue thickening that forms tumefactive lesions, tissue infiltration of lymphocytes and IgG4-positive plasma cells. IgG4-RD may appear in various organs throughout the body either synchronously or metachronously.^[@R2])^ In Japan, IgG4-RD was designated as an intractable disease in July 2017 (http://www.nanbyou.or.jp/entry/4505).

It was shown that some, albeit not all, instances of periaortitis, periarteritis, inflammatory aortic aneurysm, and mediastinal fibrosis may occur as part of the IgG4-RD spectrum.^[@R3]--[@R5])^ For example, Kasashima et al. showed in their histopathologic study that some cases of inflammatory aortic aneurysms can be categorized as IgG4-RD.^[@R6])^ In addition, Perugino et al. more recently reported several cases of IgG4-related vasculitis affecting the aorta and peripheral arteries including coronary, carotid, and iliac arteries, indicating that large vessel vasculitis is one of the features of IgG4-RD.^[@R7])^

As the concept of IgG4-RD became widely acknowledged, measurement of serum IgG4 level is more frequently performed among patients who are suspected of having IgG4-RD. Hamano et al. reported that, when the serum IgG4 of 135 mg/dL or higher is set as the cut-off level, autoimmune pancreatitis (IgG4-RD) can be differentiated from other non-IgG4-related pancreatic diseases, such as pancreatic cancer, with a high sensitivity (95%) and a high specificity (97%).^[@R1])^ To date, it is not known whether this cut-off level (135 mg/dL) provides a strong enough ground for diagnosing IgG4-related vasculitis among various cardiovascular disorders. In the present study, we measured serum IgG4 levels in patients with various cardiovascular disorders, and determined the range of serum IgG4 levels among them.

Subjects and Methods
====================

Subjects
--------

This study was approved by the Institutional Review Board of Osaka Medical College. After obtaining written informed consent, serum IgG4 levels were measured in patients who were admitted to the Department of Cardiology and in those who underwent electrocardiography (ECG)-gated computed tomography (CT). Medical records in these patients were checked whether patients had been diagnosed or suspected with IgG4-RD in cardiovascular or in other organs.

Measurement of IgG4 levels
--------------------------

Measurement of IgG4 levels was outsourced to LSI Medience Co. (Tokyo, Japan).

Statistical analyses
--------------------

Statistical analyses were conducted using SPSS Statistics version 22 (IBM, New York, NY, USA).

Results
=======

This study included 477 patients who were admitted to the cardiology department (inpatient group) and 401 patients who underwent ECG-gated CT (CT group). ECG-gated CT was performed mainly for the evaluation of coronary artery. Forty-four patients were found to be included in both groups; however, due to the difference in the timing of blood sampling, serum IgG4 value was not identical for the same patient.

Cardiology inpatients
---------------------

### Patient clinical features and serum IgG4 levels

[**Table 1**](#table1){ref-type="table"} demonstrates clinical features of inpatient group. The correlation of serum IgG4 with albumin/globulin (A/G) ratio among 477 inpatients is shown in [**Fig. 1**](#figure1){ref-type="fig"}, and serum IgG4 levels of these patients are shown in [**Fig. 2A**](#figure2){ref-type="fig"}. In men, the median IgG4 level was 40.4 mg/dL (interquartile range \[IQR\], 19.4--65.6 mg/dL), which was significantly higher than that in women (median, 26.2 mg/dL; IQR, 16.3--47.6 mg/dL, P=0.001, Mann--Whitney test). Overall, 23/477 (4.8%) patients were found to have IgG4 levels ≥135 mg/dL, and elevated IgG4 level was significantly more prevalent in men (22/341 \[6.5%\]) than in women (1/136 \[0.7%\], P=0.007, Chi-square test). Case no. 14 of inpatient group (InPt-case 14) had been diagnosed with Mikulicz disease before enrollment of the study, and case no. 3 (InPt-case 3) had been diagnosed with IgG4-related coronary periarteritis at our department ([**Table 2**](#table2){ref-type="table"}). No other patients had previously been diagnosed with IgG4-RD at the time of study enrollment.

###### Table 1 Characteristic of cardiac inpatients

  ------------------------------------------ -------------------
  No. of subjects                            477
  Age, years                                 68.4±10.8
  Women, n (%)                               136 (28.5)
  BMI, kg/m^2^                               23.3±3.4
  Systolic blood pressure, mmHg              127±19
  Chronic hemodialysis, n (%)                11 (2.3)
  *Smoking status*                           
    Never (%)                                113 (83.1)
    Former (%)                               19 (14.0)
    Current (%)                              4 (2.9)
  *Cardiovascular disease*                   
    Ischemic heart disease, n (%)            304 (63.7)
    Arrhythmic disease, n (%)                105 (22.0)
    Peripheral artery disease, n (%)         41 (8.6)
    Valvular heart disease, n (%)            61 (12.8)
    Cardiomyopathy, n (%)                    32 (6.7)
    Aneurysmal disease, n (%)                31 (6.5)
  *Laboratory data*                          
    White blood cell count, ×10^3^/µL        6.2±1.9
    Hemoglobin, g/dL                         13.2±1.7
    Platelet count, ×10^4^/µL                22.0±6.4
    Total protein, g/dL                      6.9±0.6
    Albumin, g/dL                            3.9±0.4
    IgG4, median (IQR) mg/dL                 34.2 (18.4--59.5)
    Creatinine\*, mg/dL                      0.96±0.52
    eGFR\*, mL/min/1.73 m^2^                 51.8±20.4
    C-reactive protein, median (IQR) mg/dL   0.11 (0.04--0.40)
  ------------------------------------------ -------------------

\*Excluding those with hemodialysis.

Data are presented as the mean±standard deviation or the median and interquartile range (IQR).

![Fig. 1 Correlation between serum IgG4 and albumin/globulin ratio among cardiology inpatients.](avd-11-4-oa.18-00103-figure01){#figure1}

![Fig. 2 Distribution of the serum IgG4 levels.](avd-11-4-oa.18-00103-figure02){#figure2}

###### Table 2 Clinical diagnosis of cardiac inpatients with increased serum IgG4 concentrations

                  IgG4, mg/dL   Age, years   Sex   Cardiovascular disease                                                     Accompanying conditions
  --------------- ------------- ------------ ----- -------------------------------------------------------------------------- ----------------------------------------------
  InPt-case 1     1240          77           M     Orthostatic hypotension                                                    Prostate cancer
  InPt-case 2     830           46           M     Cardiac dysfunction                                                        Eosinophilic granulomatosis with polyangitis
  InPt-case 3     564           67           M     Ischemic heart disease                                                     
  InPt-case 4     387           75           F     Suspected ischemic heart disease                                           
  InPt-case 5     331           75           F     Heart failure                                                              Lung cancer
  InPt-case 6     331           62           M     Arteriosclerosis obliterans                                                
  InPt-case 7\*   366           67           M     Suspected infected aortic aneurysm                                         
  InPt-case 8     204           60           M     Congestive heart failure                                                   History of influenza associated myocarditis
  InPt-case 9     187           74           M     Abdominal aortic aneurysm, silent myocardial ischemia                      
  InPt-case 10    184           71           M     After coronary stent implantation                                          Maxillar cyst, post operation
  InPt-case 11    172           76           M     Aortic regurgitation                                                       
  InPt-case 12    165           75           M     Silent myocardial ischemia                                                 Common iliac artery dissection
  InPt-case 13    164           81           M     Effort angina pectoris                                                     
  InPt-case 14    162           81           M     Gait disturbance                                                           Mikulicz disease
  InPt-case 15    155           69           M     Arteriosclerosis obliterans                                                
  InPt-case 16    154           56           M     Old myocardial infarction                                                  
  InPt-case 17    154           79           M     Worsening heart failure                                                    
  InPt-case 18    152           77           M     Ischemic heart disease                                                     
  InPt-case 19    151           88           M     After coronary stent implantation                                          Prostatomegaly
  InPt-case 20    144           59           M     Ischemic heart disease                                                     
  InPt-case 21    142           65           M     Congestive heart failure, old myocardial infarction, atrial fibrillation   
  InPt-case 22    141           51           M     Unstable angina pectoris                                                   
  InPt-case 23    139           78           M     After coronary stent implantation                                          

\*InPt-case 7 is the same patient as CT-case 5 in [**Table 4**](#table4){ref-type="table"}.

Serum IgG4 levels were significantly correlated with serum total protein (TP) (r=0.16, P\<0.001), albumin (Alb) (r=−0.10, P=0.026), and A/G ratio (r=−0.11, P=0.017, Spearman's test) ([**Fig. 1**](#figure1){ref-type="fig"}). Among 52 patients with low A/G ratio (\<1.0), high serum IgG4 levels (≥135 mg/dL) was observed in 9 (17%) patients, the prevalence of which was significantly greater than that among 425 patients with an A/G ratio of ≥1.0 (14 patients \[3.3%\], P\<0.0001, Chi-square test). Relationship between serum IgG4 and A/G ratio remained statistically significant even after excluding those who had low serum albumin (\<3.9 mg/dL) from the analysis (r=−0.21, P\<0.001, Spearman's test). Serum IgG4 levels were not significantly correlated with age (r=0.04, P=0.429), body mass index, white blood cell count, hemoglobin, platelet (PLT) count, or uric acid. In InPt-case 3, who had been diagnosed with IgG4-related coronary periarteritis, serum TP and Alb levels were 4.0 g/dL and 7.7 g/dL, respectively, and A/G ratio was 1.08.

The cardiovascular diseases that led to hospitalization of the 23 patients with elevated serum IgG4 levels and accompanying conditions are described in [**Table 2**](#table2){ref-type="table"}. We reported, in the previous paper, two cases in the list; InPt-case 3 who had been diagnosed with IgG4-related coronary periarteritis,^[@R8],[@R9])^ and InPt-case 7 (the same as CT-case 5) who were initially diagnosed with infected aortic aneurysm, and tissue infiltration of IgG4-positive cell was later demonstrated in the surgical samples of aneurysmal wall.^[@R10])^

### Inpatient case with the highest IgG4 levels

The patient who had the highest serum IgG4 level among inpatient group (InPt-case 1) was a 77-year-old man ([**Table 2**](#table2){ref-type="table"}). Four months prior to admission, prostate cancer was diagnosed histologically in this patient, and medical therapy (leuprorelin acetate and bicalutamide) was started. Thereafter, he started to feel dizziness that may be caused by orthostatic hypotension, and was admitted to our department. Abdominal CT revealed a soft tissue mass near the right ureteropelvic junction ([**Fig. 3A**](#figure3){ref-type="fig"}), around the iliac arteries and abdominal aorta ([**Figs. 3B** and **3C**](#figure3){ref-type="fig"}), and at the pelvic floor ([**Fig. 3D**](#figure3){ref-type="fig"}). Although they might be IgG4-related lesions, definitive diagnosis of IgG4-RD could not be made, because tissue samples were not available. There were no other lesions suspected of IgG4-RD, including pancreas. Serum TP and Alb levels were 9.2 mg/L and 3.8 mg/dL, respectively, and an A/G ratio was 0.70. White blood cell count was 8,470/µL with an eosinophil fraction of 8.4% (eosinophil count, 711/µL), thus eosinophilia was present. The underlying cause of orthostatic hypotension remained unidentified. The patient was treated with elastic stocking wear.

![Fig. 3 Computed tomography images of cardiac inpatients who showed the highest serum IgG4 level among this group (InPt-case 1).](avd-11-4-oa.18-00103-figure03){#figure3}

Clinical features of patients who underwent ECG-gated CT
--------------------------------------------------------

### Clinical features and serum IgG4 levels of patients

[**Table 3**](#table3){ref-type="table"} demonstrates clinical features of patients in CT group. Although the most frequent reason for undergoing ECG-gated CT was to diagnose or follow-up coronary artery lesions, to acquire the left atrium images was another reason in patients with atrial fibrillation. The median IgG4 level was 43.7 mg/dL (IQR, 28.6--73.1 mg/dL) in men, which was significantly higher than that in women (32.2 mg/dL, IQR, 19.4--53.4 mg/dL, P\<0.001, Mann--Whitney test). In CT group, a weak yet significant positive correlation was observed between age and IgG4 levels (r=0.11, P=0.030, Spearman's test).

###### Table 3 Characteristic of patients who underwent EGC-gated computed tomography

  --------------------------------------------- -------------------
  No. of subjects                               401
  Age, years                                    67.2±10.8
  Women, n (%)                                  163 (40.6)
  BMI, kg/m^2^ (n=381)                          23.7±3.6
  Chronic hemodialysis, n (%)                   11 (2.7)
  *Smoking status* (n=335)                      
    Never (%)                                   213 (63.6)
    Former/current (%)                          122 (36.4)
  *Laboratory data*                             
    White blood cell count, ×10^3^/µL (n=379)   5.9±1.7
    Hemoglobin, g/dL (n=380)                    13.7±2.3
    Platelet count, ×10^4^/µL (n=380)           22.1±7.4
    Total protein, g/dL (n=401)                 7.1±0.5
    Albumin, g/dL (n=401)                       4.1±0.4
    IgG4, (IQR) mg/dL                           38.7 (24.8--62.9)
    Creatinine\*, mg/dL (n=390)                 0.84±0.42
    eGFR\*, mL/min/1.73 m^2^ (n=390)            68.4±16.9
  --------------------------------------------- -------------------

\*Excluding those with hemodialysis.

Data are presented as the mean±standard deviation or the median and interquartile range (IQR).

[**Figure 2B**](#figure2){ref-type="fig"} presents the distribution of serum IgG4 levels among the 401 patients who underwent ECG-gated CT. Elevated level of serum IgG4 (≥135 mg/dL) was found in 17 patients (4.2%), and no significant difference in the proportion of elevated serum IgG4 levels was noted between women (5/163 \[3.1%\] ) and men (12/238 \[5.5%\], P=0.451). In the CT group, no patients had a prior diagnosis of IgG4-RD. The reason for undergoing CT and accompanying conditions in 14 patients with high IgG4 levels (≥135 mg/dL) are described in [**Table 4**](#table4){ref-type="table"}. Case no. 5 of CT group (CT-case 5) is the same patient as InPt-case 7.^[@R10])^

###### Table 4 Clinical diagnosis of patients undergoing EGC-gated computed tomography with increased serum IgG4 concentrations

                IgG4, mg/dL   Age, years   Sex   Cardiovascular disease                                   Accompanying conditions
  ------------- ------------- ------------ ----- -------------------------------------------------------- -------------------------------------------------------------------
  CT-case 1     877           78           M     Syncope                                                  Gastric cancer, post operation
  CT-case 2     317           70           M     Paroxysmal atrial fibrillation                           
  CT-case 3     215           68           M     Ischemic heart disease                                   Suspected intraductal papillary mucinous neoplasm of the pancreas
  CT-case 4     197           75           F     Suspected angina pectoris                                Gastric carcinoid, post operation
  CT-case 5\*   193           67           M     Suspected infected aortic aneurysm                       
  CT-case 6     188           65           M     Congestive heart failure                                 Mediastinal lymphadenopathy
  CT-case 7     185           77           M     Dilatation of the ascending aorta                        Mediastinal lymphadenopathy
  CT-case 8     168           70           F     Suspected angina pectoris                                
  CT-case 9     164           78           F     Dizziness                                                Mediastinal tumor
  CT-case 10    162           81           F     Suspected angina pectoris                                Lung cancer
  CT-case 11    158           73           M     Suspected angina pectoris                                
  CT-case 12    152           72           M     Suspected silent myocardial ischemia                     
  CT-case 13    149           73           M     Suspected angina pectoris, pulmonary artery thrombosis   
  CT-case 14    141           72           F     Suspected angina pectoris                                Idiopathic thrombocytopenic purpura
  CT-case 15    138           62           M     Suspected angina pectoris                                
  CT-case 16    138           74           M     Atrial fibrillation                                      
  CT-case 17    135           80           M     Atrial fibrillation                                      

\*CT-case 5 is the same patient as InPt-case 7 in [**Table 2**](#table2){ref-type="table"}.

### ECG-gated CT case with the highest IgG4 levels

The patient who showed highest serum IgG4 levels in this group (CT-case 1) was a 78-year-old man ([**Table 4**](#table4){ref-type="table"}). Five months prior to the CT examination, the patient underwent surgery for advanced gastric cancer. Detailed cardiovascular check-up, including coronary artery evaluation, was performed to identify the reason for sycope. Abdominal CT revealed a soft tissue mass encasing the abdominal aorta, common iliac artery, and internal iliac artery (marked perivascular thickening; [**Figs. 4A**--**4C**](#figure4){ref-type="fig"}). ECG-gated CT revealed no significant stenosis or periarterial thickening in the coronary artery ([**Figs. 4D**--**4F**](#figure4){ref-type="fig"}). No abnormal findings were found in the pancreas.

![Fig. 4 Computed tomography images of the patient undergoing ECG-gated computed tomography who showed the highest serum IgG4 level among this group (CT-case 1).](avd-11-4-oa.18-00103-figure04){#figure4}

Laboratory data from this patient showed a TP of 7.6 mg/L, Alb of 3.3 mg/dL, and a A/G ratio of 0.77. The white blood cell count was 8,310/µL with the eosinophil fraction of 4.5%. The patient is undergoing periodic radiological follow-up without corticosteroid therapy. Similar degree of periarterial thickening was observed in CT images that was taken approximately 4 years later.

Discussion
==========

In the current study, we comprehensively measured serum IgG4 levels, after obtaining written informed consent, in 477 patients who were admitted to cardiology department and in 401 patients who underwent ECG-gated CT. Twenty-three (4.8%) subjects of 477 inpatient group and 17 (4.2%) of 401 CT group were found to have IgG4 levels ≥135 mg/dL. Examination of the medical records of those patients revealed that one of these patients had been diagnosed with Mikulicz disease (InPt-case 14) and another with IgG4-related coronary periarteritis (InPt-case 3), but IgG4-RD had not previously been diagnosed or suspected except these two cases. Radiologic images of patients who had the highest serum IgG4 levels in the inpatient group and CT group demonstrated a soft tissue mass encasing the arteries (marked periarterial thickening; [**Figs. 3**](#figure3){ref-type="fig"} and [**4**](#figure4){ref-type="fig"}) suggestive of IgG4-RD; however, due to the lack of tissue samples, a definite diagnosis of IgG4-RD could not be made.

It was found that patients with elevated IgG4 levels had relatively low A/G ratios. Serum IgG4 level had significantly negative correlation with A/G ratio even when patients who had low serum albumin level (\<3.9 mg/dL) were excluded from the analysis. Although those with low A/G ratio (\<1.0) were more likely to have higher serum IgG4 levels, the A/G ratio was \>1.0 in the case who had been diagnosed with IgG4-related coronary periarteritis (InPt-case 3) in which serum IgG4 was 564 mg/dL; therefore, the A/G ratio of \>1.0 may not be able to completely rule out the high serum IgG4 levels or possibility of IgG4-RD. A/G ratio may be affected by various factors, such as malnutrition, but the clinical importance of A/G ratio for diagnosing/suspecting elevated IgG4 should be analyzed in future studies.

In general, IgG4-RD is not a life-threatening disease, however, its involvement of cardiovascular system can sometimes be fatal, through the rupture of vascular wall. In addition, possibility exists that corticosteroid therapy, which is effective controlling the activity of IgG4-RD, might decrease the thickness of perivascular tissue and promote the fragilization of the vascular wall. IgG4-related cardiovascular lesion should be treated with particular caution,^[@R11],[@R12])^ although proper diagnosis of IgG4-related cardiovascular lesions may be more difficult than IgG4-RD that affects other organs.

In the comprehensive diagnostic criteria (CDC) of IgG4-RD, definitive diagnosis requires the presence of fibro-inflammatory tissue thickening, elevated serum IgG4 levels, and the histopathological proof of IgG4-positive plasma cell infiltration.^[@R13])^ However, tissue sampling from the heart and/or large vessels carries considerable risks, even if not impossible. Therefore, using only CDC may result in the under-diagnosis of IgG4-related cardiovascular disease.

In addition to CDC, there is so-called "organ-specific diagnostic criteria" in some non-cardiovascular organs, such as the pancreas and lachrymal and salivary glands. The organ-specific criteria may enable a definitive diagnosis even when histopathological assessment is not present,^[@R14],[@R15])^ because the radiologic image may present characteristic findings of IgG4-RD. On the other hand, IgG4-related cardiovascular disease does not demonstrate specific radiologic findings.^[@R16])^ Therefore, a definitive diagnosis of IgG4-related cardiovascular disease cannot be made only from radiologic findings without histopathologic finding or accompanying definitively diagnosed IgG4-RD in non-cardiovascular organs. To which extent the elevated serum IgG4 levels (≥135 mg/dL) support that possibility of IgG4-related cardiovascular disease has not been clear.

Hamano et al. reported that using an IgG4 cut-off level of ≥135 mg/dL, they could differentiate autoimmune pancreatitis, which is an IgG4-RD, from other pancreatic diseases with a sensitivity of 95% and specificity of 97%.^[@R1])^ In the present study, in both inpatient group and CT group, serum IgG4 levels ≥135 mg/dL was observed in more than 4% of the subjects, but IgG4-RD had not been diagnosed in most of these cases. Therefore, exceeding serum IgG4 cut-off value of 135 mg/dL is not an exclusive finding in IgG4-related cardiovascular disease. Periarterial thickening, a radiologic finding of IgG4-related periaortitis/periarteritis, is often resemble that observed in other diseases or conditions, such as atherosclerosis. Considering that atherosclerotic vascular changes are frequently observed among cardiology patients, taking the elevation of serum IgG4 levels as the diagnostic ground among them may lead to overdiagnosis of IgG4-related vascular disease.

It may be questioned what would be the clinical importance in making the diagnosis of IgG4-related cardiovascular disease. We still cannot fully answer this question, but there are several possibilities. First, the popularization of the concept of IgG4-RD has led to an increase in the number of patients diagnosed with IgG4-RD of various organs. As IgG4-RD can either synchronously or metachronously appear in various organs throughout the body; therefore, IgG4-related vascular lesions may emerge during the clinical course of patients with IgG4-RD in non-vascular organs.^[@R17])^ In fact, we encountered a patient with autoimmune pancreatitis, who developed IgG4-related coronary periarteritis/aneurysm and required coronary artery bypass surgery.^[@R18])^ Second, in reverse, in cases in which heart and vessels are the index organs for the diagnosis of IgG4-RD, we can anticipate the possible emergence of IgG4-RD in other organs, and plan to perform appropriate systemic search. Third, as incidence of malignant disorder is reported to be higher in patients with IgG4-RD,^[@R19])^ diagnosis of IgG4-RD may make us aware of the necessity of careful exclusion of malignant disease. Fourth, although corticosteroid therapy is generally effective in controlling the activity of IgG4-RD, it might promote fragilization of vessel wall of IgG4-related vascular disease, leading to the expansion and rupture of the vessels.^[@R11])^ Finally, in Japan, IgG4-RD has been designated as an intractable disease, thus, proper diagnosis and appropriate treatment for cardiovascular involvement of IgG4-RD is needed.

Conclusion
==========

We comprehensively measured serum IgG4 levels in 477 patients who were admitted to the cardiology department and in 401 patients who underwent ECG-gated CT. It was found that 23 patients (4.8%) in inpatient group and 14 patients (4.2%) in CT group had serum IgG4 levels ≥135 mg/dL. On the other hand, only in two patients with high serum IgG4 level were found to have been diagnosed with IgG4-RD. Histopathological assessment of cardiovascular tissue for the diagnosis of IgG4-RD is often difficult due to the potential risk of tissue sampling. In addition, there are no specific radiologic findings of IgG4-related cardiovascular disease, high serum IgG4 level (≧135 mg/dL) alone may not provide sufficient grounds for the diagnosis of IgG4-cardiovascular disease, because serum IgG4 level ≥135 mg/dL can be observed in more than 4% in cardiology patients. To avoid over-diagnosis and inappropriate treatment, diagnosis of IgG4-related cardiovascular disease should carefully be made especially when histopathologic analysis of cardiovascular tissue is not available.

The present study was conducted with a Grant in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, and with a Grant in Aid for Scientific Research from the Ministry of Health, Labour and Welfare of Japan.

The authors have no conflicts of interest to disclose with regard to the present study.
